Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (151-160 of 244) with videos related to

Pageof 25
Sort By:
Scandinavian Journal of Gastroenterology|February 1, 2019
Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patientsÅsa H Everhov, Michael C Sachs, Petter Malmborg, et al.
Inflammatory Bowel Diseases|September 18, 2009
Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patientsLeif Törkvist, Jonas Halfvarson, Rick T H Ong, et al.
Therapeutic Advances in Gastroenterology|June 19, 2025
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phaseLisa Nyberg, Jonas Halfvarson, Jonas Söderling, et al.
Digestive Diseases (Basel, Switzerland)|February 7, 2019
Unmet Medical Needs in Ulcerative Colitis: An Expert Group ConsensusSilvio Danese, Matthieu Allez, Ad A van Bodegraven, et al.
Plos One|December 14, 2016
Functional Analyses of the Crohn's Disease Risk Gene LACC1Ghazaleh Assadi, Liselotte Vesterlund, Ferdinando Bonfiglio, et al.
Journal of Crohn'S & Colitis|January 29, 2016
Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's DiseaseKarin Amcoff, Marie Joossens, Marie J Pierik, et al.
Journal of Crohn'S & Colitis|November 4, 2024
Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter StudyBenita Salomon, Padhmanand Sudhakar, Daniel Bergemalm, et al.
Therapeutic Advances in Gastroenterology|June 5, 2023
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension studyIsabella Visuri, Carl Eriksson, Sara Karlqvist, et al.
Scandinavian Journal of Gastroenterology|September 10, 2019
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality registerJonas F Ludvigsson, Marie Andersson, Jonas Bengtsson, et al.
Plos One|January 5, 2012
Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1)Francesca Anedda, Marco Zucchelli, Danika Schepis, et al.
Pageof 25

Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
Scandinavian Journal of Gastroenterology|February 1, 2019
Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patientsÅsa H Everhov, Michael C Sachs, Petter Malmborg, et al.
Inflammatory Bowel Diseases|September 18, 2009
Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patientsLeif Törkvist, Jonas Halfvarson, Rick T H Ong, et al.
Therapeutic Advances in Gastroenterology|June 19, 2025
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phaseLisa Nyberg, Jonas Halfvarson, Jonas Söderling, et al.
Digestive Diseases (Basel, Switzerland)|February 7, 2019
Unmet Medical Needs in Ulcerative Colitis: An Expert Group ConsensusSilvio Danese, Matthieu Allez, Ad A van Bodegraven, et al.
Plos One|December 14, 2016
Functional Analyses of the Crohn's Disease Risk Gene LACC1Ghazaleh Assadi, Liselotte Vesterlund, Ferdinando Bonfiglio, et al.
Journal of Crohn'S & Colitis|January 29, 2016
Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's DiseaseKarin Amcoff, Marie Joossens, Marie J Pierik, et al.
Journal of Crohn'S & Colitis|November 4, 2024
Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter StudyBenita Salomon, Padhmanand Sudhakar, Daniel Bergemalm, et al.
Therapeutic Advances in Gastroenterology|June 5, 2023
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension studyIsabella Visuri, Carl Eriksson, Sara Karlqvist, et al.
Scandinavian Journal of Gastroenterology|September 10, 2019
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality registerJonas F Ludvigsson, Marie Andersson, Jonas Bengtsson, et al.
Plos One|January 5, 2012
Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1)Francesca Anedda, Marco Zucchelli, Danika Schepis, et al.
Pageof 25